Alnylam Pharmaceuticals
ALNY
$143.31
Share price
-0.28%
Change (1 day)
-27.45%
Change (1 year)
Categories
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
We have found no dividend yields for this company